Page 86 - Journal of Special Operations Medicine - Fall 2016
P. 86

dietary supplement.  This is a common situation in the   physical activity may be performed by the Soldier. Once
                             53
            military and other situations where training or testing   the evaluation is completed and satisfactory, the indi-
            may involve large groups of individuals. 11,29,54,55  There   vidual can gradually return to activity using the criteria
            may be other individuals with similar symptoms who   for the lower-risk individual. 48
            have not sought immediate medical care.
                                                               Primary Prevention
            Return to Activity                                 Primary prevention comprises actions taken to pre-
            The  great  majority  of  warfighters  who  sustain  an  ER   vent the development of ER and is the ultimate goal of
            episode recover and return to duty without consequence   public health efforts to minimize the incidence of this
            or increased risk for future recurrence.  Return to phys-  problem.  Several studies have shown that the exercise-
                                                                       57
                                             56
            ical activity in a warfighter, however, does require de-  induced rise in serum CK and myoglobin levels can be
            termining who may be at risk for recurrence, because   reduced  by  a  period  of  preconditioning  before  more
            the risk not only involves the individual but may have   intense physical training. 58,59  This adaptation may be
            operational impact on the unit. Table 1 provides guide-  mediated by a training-induced increase in the size and
            lines that medical providers can use to make this deter-  number of mitochondria in the myocytes  that can pro-
                                                                                                  60
            mination. For the patient at low risk, or if physiological   vide additional adenosine triphosphate (ATP) to assist
            ER is involved,  a three-phase program  for returning   in stabilizing cellular walls during exercise. Risk for ER
            the Soldier to duty is described in Table 2. If an indi-  in normal healthy individuals can be reduced by empha-
            vidual appear to be at higher risk, based on the Table   sizing graded, individual preconditioning before begin-
            1 guidelines, further evaluation is recommended. These   ning a more strenuous exercise regimen and/or group
            evaluations include a complete history and physical ex-  exercise. In group activity, exercises of specific muscle
            amination, along  with a consultation  with a regional   groups (common in calisthenics-type exercises) should
            or national ER expert to rule out myopathic disorders.   be introduced gradually, starting with only a few rep-
            Other diagnostic tests may be called for (e.g., muscle   etitions and emphasizing the correct form. Sudden in-
            biopsies, electromyographic studies, caffeine–halothane   creases in exercise volume should be avoided. The US
            muscle contracture tests, and/or progressive exercise   Army Field Manual 7-22 provides progression sched-
            challenge test). While the evaluation is ongoing, light   ules for a very wide variety of exercises.


            Table 1  Criteria to Assist in Determination of Patients Who Might Be at High or Lower Risk for Recurrence of
            Exertional Rhabdomyolysis a
             Suspicion of High Risk: At least one of the following   Lower Risk: None of the high-risk conditions should exist
             conditions must be present:                      and at least one of the following conditions must be present:
             Delayed recovery (more than 1 week) when activities have   Rapid clinical recovery and CK normalization after exercise
             been restricted                                  restrictions
             Personal or family history of recurrent muscle cramps or   No family history of rhabdomyolysis or previous reporting
             severe muscle pain that interferes with activities of daily   of debilitating exercise-induced muscle pain, cramps, or heat
             living or sports and/or exercise performance     injury
             Personal or family history of malignant hyperthermia,   No personal history of rhabdomyolysis or previous reporting
             or family history of unexplained complications or death   of debilitating exercise-induced muscle pain, cramps, or heat
             following general anesthesia                     injury
             Personal or family history of ER                 Existence of other group or unit-related cases of ER during
                                                              the same exercise sessions
             Personal or family history of sickle cell disease or trait  Suspected or documented concomitant viral illness or
                                                              infectious disease
             Muscle injury after low to moderate work or activity  Sufficiently fit or well-trained individual with a history of
                                                              very intense training/exercise bout
             ER complicated by acute renal injury of any degree  Taking a drug or dietary supplement that could contribute to
                                                              the development of ER
             Persistent elevation of CK (greater than 5 times the upper
             limit of the normal laboratory range) despite rest for at least
             2 weeks
             Personal history of significant heat injury (heat stroke)
             Serum CK peak ≥100,000U/L
            CK, creatine kinase; ER, exertional rhabdomyolysis.
            a Adapted from O’Connor et al. 48


            68                                        Journal of Special Operations Medicine  Volume 15, Edition 3/Fall 2016
   81   82   83   84   85   86   87   88   89   90   91